Latest / Durham News Today | 2 Min News | The Daily News Now!
mRNA Vaccine Shatters Melanoma Recurrence Odds | Durham News
A breakthrough mRNA cancer vaccine, paired with Keytruda, slashes melanoma recurrence risk—and could extend patient lives. Custom-built from a patient’s tumor DNA, it’s the first of its kind to show real survival benefits, with mild side effects. FDA approval is pending, but experts predict availability by 2027—and this approach may soon target other cancers too. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.